Every biopharma function has had to evaluate and adapt its roles and responsibilities almost overnight. So, how do we navigate the uncertain landscape ahead? We surveyed over 550 biopharma executives – from R&D to commercial – to gain practical insights on the current state and long-term outlook for the industry.
This new report explores the findings of the biggest survey conducted in North America into pharma’s operations during the COVID-19 pandemic, analyzing the results with pharma leaders to help establish a framework for more patient-focused, sustainable care delivery, Today, Tomorrow and on The Road Ahead.
Access this free 30+ page report and you will:
- See the impact of COVID-19 across the product lifecycle, highlighting commercial, HCP needs and pharma’s relationship with them, the marketing and the sales model, patient engagement, medical affairs and R&D
- Hear from pharma leaders who are plotting the industry’s re-mergence strategies into the “new normal”
- Benchmark your own response and experience to COVID-19 against hundreds of industry peers